EXAS vs RYAN · rev $2.76B vs P/E 43, rev $2.46B
EXACT Sciences Corporation (EXAS) versus Ryan Specialty Group Holdings Inc (RYAN) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Ryan Specialty Group Holdings Inc (RYAN) is a insurance - specialty company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported RYAN revenue for 2024-12-31 was $2.46B. Net income was $229.9M. Revenue was up 21.2% from 2023-12-31 to 2024-12-31. RYAN currently screens at market cap $9.33B and trailing P/E 43.1.
EXAS currently screens at market cap $20.03B. RYAN currently screens at market cap $9.33B and trailing P/E 43.1.
Not investment advice. Open the EXAS and RYAN stock pages for the full models.
Not investment advice.